The US FDA’s 2025 animal health approvals highlight a transformative year for veterinary medicine, with major advances spanning companion animal therapeutics, livestock productivity, poultry health, parasitic disease management, diagnostics, oncology, and genetic innovation. The latest wav...
Quick Takeaways: Why It Matters? Merck Animal Health is doubling down on biodevices and automation in poultry by buying TARGAN, turning from a strategic investor into full owner of high-speed sexing and precision vaccination tech Source: Businesswire...
Quick Takeaways: Why It Matters? This deal gives Merck Animal Health an early, exclusive window into a gene-therapy pipeline for chronic and age-related diseases in pets, while Rejuvenate Bio secures non-dilutive R&D support and a $6M financing round to advance its platform...
Quick Takeaways: Why It Matters? By extending Bravecto Quantum’s label to cover Asian longhorned and Gulf Coast ticks for a full 12 months, Merck further differentiates the product as the longest‑lasting, broadest‑spectrum injectable parasiticide available exclusively...
Quick Takeaways Why It Matters? Merck Animal Health strengthens its dermatology franchise with a differentiated, second-generation JAK inhibitor positioned as a convenient, first-line option for allergic pruritus. Once-daily dosing and rapid onset are likely to ...
